Evidence map›Paper›PMID 23220293›Full record

ArticleNeuropharmacology2013

Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice.

Darrick T Balu, Jill R Turner, Bethany R Brookshire, Tiffany E Hill-Smith, Julie A Blendy, Irwin Lucki

Open access · greenAbstract readComparative Study
In one paragraph

Article in Neuropharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Darrick T BaluDepartment of Pharmacology, University of Pennsylvania, Philadelphia, PA, USA.
Jill R Turner
Bethany R Brookshire
Tiffany E Hill-Smith
Julie A Blendy
Irwin Lucki
University of Pennsylvania · US

Funding

TRAINING PROGRAM IN NEUROPSYCHOPHARMACOLOGY-PREDOCTORALT32MH014654 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 1985 to 2021
$5.0M
Regulation of Neurogenesis by Stress and AntidepressantsU01MH072832 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI LUCKI, IRWIN · 2005 to 2007
$1.7M
Regulation of Hippocampal Neurogenesis by AntidepressantsR01MH086599 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI LUCKI, IRWIN · 2010 to 2013
$1.6M
Nicotinic Acetylcholine Receptors in Anxiety and DepressionF32DA026236 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI TURNER, JILL R. · 2009 to 2011
$151k
NIDA NIH HHS F32 DA026236NIMH NIH HHS R01 MH086599NIMH NIH HHS R01 MH86599NIMH NIH HHS T32 MH014654NIMH NIH HHS T32 MH14654NIMH NIH HHS U01 MH072832NIMH NIH HHS U01MH72832
6 · The paper itself

Abstract

The MRL/MpJ mouse demonstrates enhanced wound healing and tissue regeneration and increased neurotrophic mobilization to chronic antidepressant drug treatments. This study compared brain monoamine systems between MRL/MpJ and C57BL/6J mice as a potential basis for strain differences after chronic antidepressant treatment. MRL/MpJ mice had significantly higher tissue levels of serotonin and dopamine in multiple brain regions. Microdialysis studies demonstrated that baseline levels of extracellular serotonin did not differ between strains. However, acute administration of the selective serotonin reuptake inhibitor citalopram produced an increase in extracellular serotonin in the ventral hippocampus of MRL/MpJ mice that was twice as large as achieved in C57BL/6J mice. The greater effects in MRL/MpJ mice on 5-HT levels were not maintained after local perfusion of citalopram, suggesting that mechanisms outside of the hippocampus were responsible for the greater effect of citalopram after systemic injection. The density of serotonin and norepinephrine transporters in the hippocampus was significantly higher in MRL/MpJ mice. In addition, the expression of 5-HT(1A) mRNA was lower in the hippocampus, 5-HT(1B) mRNA was higher in the hippocampus and brainstem and SERT mRNA was higher in the brain stem of MRL/MpJ mice. The exaggerated neurotransmitter release in MRL/MpJ mice was accompanied by reduced baseline immobility in the tail suspension test and a greater reduction of immobility produced by citalopram or the tricyclic antidepressant desipramine. These data suggest that differences in the response to acute and chronic antidepressant treatments between the two strains could be attributed to differences in serotonin or catecholamine transmission.

Indexed as

AnimalsAntidepressive AgentsBiogenic MonoaminesBrainMaleMiceMice, Inbred C57BLMice, Inbred MRL lprSpecies SpecificityTreatment OutcomeAntidepressive AgentsBiogenic Monoamines

Identifiers

PMID23220293
PMCPMC3587166
OpenAlexW2044568503

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.